Paper41301487
Heteroaromatic Hybrid Benzimidazole/Oxadiazole (BZ/OZ) Ligand and Its Sm(III) Complex: Study of Their Antibacterial Activity, Toxicological Prediction and Interaction with Different Model Membranes.
Aragón-Muriel A and 5 others. Biomolecules, 2025. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. Heteroaromatic Hybrid Benzimidazole/Oxadiazole (BZ/OZ) Ligand and Its Sm(III) Complex: Study of Their Antibacterial Activity, Toxicological Prediction and Interaction with Different Model Membranes. Papers, record 41301487. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41301487
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Heteroaromatic Hybrid Benzimidazole/Oxadiazole (BZ/OZ) Ligand and Its Sm(III) Complex: Study of Their Antibacterial Activity, Toxicological Prediction and Interaction with Different Model Membranes.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Oxadiazoles | Major topic |
| Benzimidazoles | Major topic |
| Anti-Bacterial Agents | Major topic |
| Coordination Complexes | Major topic |
| Microbial Sensitivity Tests | |
| Ligands | |
| Gram-Positive Bacteria | |
| Membranes, Artificial | |
| Animals | |
| Gram-Negative Bacteria |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| VIN2024203 | University of Magdalena | PubMed |
Source PubMed
References60
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11933020 | Chemical control of phospholipid distribution across bilayer membranes. | Med Res Rev | 2002 | https://conductscience.org/library/papers/11933020 | PubMed |
| 2 | 38825827 | New benzimidazole-oxadiazole derivatives as potent VEGFR-2 inhibitors: Synthesis, anticancer evaluation, and docking study. | Drug Dev Res | 2024 | https://conductscience.org/library/papers/38825827 | PubMed |
| 3 | 40028103 | Novel Benzimidazole-Oxadiazole Derivatives as Anticancer Agents with VEGFR2 Inhibitory Activity: Design, Synthesis, In Vitro Anticancer Evaluation, and In Silico Studies. | ACS Omega | 2025 | https://conductscience.org/library/papers/40028103 | PubMed |
| 4 | 35014650 | Diffuse scattering from lamellar structures. | Soft Matter | 2022 | https://conductscience.org/library/papers/35014650 | PubMed |
| 5 | 12719241 | Mechanism of the lamellar/inverse hexagonal phase transition examined by high resolution x-ray diffraction. | Biophys J | 2003 | https://conductscience.org/library/papers/12719241 | PubMed |
| 6 | 34209520 | Antimicrobial Activity of 1,3,4-Oxadiazole Derivatives. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34209520 | PubMed |
| 7 | 40558172 | Design and Synthesis of Hybrid Compounds for Potential Treatment of Bacterial Co-Infections: In Vitro Antibacterial and In Silico Studies. | Antibiotics (Basel) | 2025 | https://conductscience.org/library/papers/40558172 | PubMed |
| 8 | 32811204 | Synthesis, anticancer evaluation and molecular docking studies of new benzimidazole- 1,3,4-oxadiazole derivatives as human topoisomerase types I poison. | J Enzyme Inhib Med Chem | 2020 | https://conductscience.org/library/papers/32811204 | PubMed |
| 9 | 29924618 | Anticancer Agent Edelfosine Exhibits a High Affinity for Cholesterol and Disorganizes Liquid-Ordered Membrane Structures. | Langmuir | 2018 | https://conductscience.org/library/papers/29924618 | PubMed |
| 10 | 22840417 | Benzimidazole bearing oxadiazole and triazolo-thiadiazoles nucleus: design and synthesis as anticancer agents. | Bioorg Med Chem Lett | 2012 | https://conductscience.org/library/papers/22840417 | PubMed |
| 11 | 33373844 | A comparison of the location in membranes of curcumin and curcumin-derived bivalent compounds with potential neuroprotective capacity for Alzheimer's disease. | Colloids Surf B Biointerfaces | 2021 | https://conductscience.org/library/papers/33373844 | PubMed |
| 12 | 39155152 | Benzimidazole-Oxadiazole Hybrids-Development in Medicinal Chemistry: An Overview. | Chem Biol Drug Des | 2024 | https://conductscience.org/library/papers/39155152 | PubMed |
| 13 | 37895901 | Hierarchical Virtual Screening of Potential New Antibiotics from Polyoxygenated Dibenzofurans against Staphylococcus aureus Strains. | Pharmaceuticals (Basel) | 2023 | https://conductscience.org/library/papers/37895901 | PubMed |
| 14 | 37716963 | Chalcone/1,3,4-Oxadiazole/Benzimidazole hybrids as novel anti-proliferative agents inducing apoptosis and inhibiting EGFR & BRAFV600E. | BMC Chem | 2023 | https://conductscience.org/library/papers/37716963 | PubMed |
| 15 | 7696476 | Components of the carbonyl stretching band in the infrared spectra of hydrated 1,2-diacylglycerolipid bilayers: a reevaluation. | Biophys J | 1994 | https://conductscience.org/library/papers/7696476 | PubMed |
| 16 | 36015376 | Fluoroquinolones Hybrid Molecules as Promising Antibacterial Agents in the Fight against Antibacterial Resistance. | Pharmaceutics | 2022 | https://conductscience.org/library/papers/36015376 | PubMed |
| 17 | 10563802 | Fourier transform infrared spectroscopic studies of the interaction of the antimicrobial peptide gramicidin S with lipid micelles and with lipid monolayer and bilayer membranes. | Biochemistry | 1999 | https://conductscience.org/library/papers/10563802 | PubMed |
| 18 | 25579799 | Synthesis, spectroscopic, thermal and antimicrobial studies of neodymium(III) and samarium(III) complexes derived from tetradentate ligands containing N and S donor atoms. | Spectrochim Acta A Mol Biomol Spectrosc | 2015 | https://conductscience.org/library/papers/25579799 | PubMed |
| 19 | 32548326 | Synthesis, biological evaluation and model membrane studies on metal complexes containing aromatic N,O-chelate ligands. | Heliyon | 2020 | https://conductscience.org/library/papers/32548326 | PubMed |
| 20 | 36531969 | Antimicrobial Agents Based on Metal Complexes: Present Situation and Future Prospects. | Int J Biomater | 2022 | https://conductscience.org/library/papers/36531969 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42819794 | Evolution of Metal-Based Anticancer Therapeutics: Chemical Foundations, Platinum Drugs, and Emerging Schiff Base Ruthenium(II) and Iridium(III) Complexes. | ACS Omega | 2026 | https://conductscience.org/library/papers/42819794 | PubMed |
| 42192699 | Antibacterial and Antibiofilm Potential of Thymol-Benzimidazolium-Chalcone Hybrids Against Clinical MRSA Strains: Insights from Gene Expression Profiling and Molecular Docking. | Antibiotics (Basel) | 2026 | https://conductscience.org/library/papers/42192699 | PubMed |
| 41828831 | Synthesis, Characterization, and Bioactivity Investigation of Novel Benzimidazole Derivatives as Potential Antibacterial and Antifungal Agents. | Molecules | 2026 | https://conductscience.org/library/papers/41828831 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41301487
GET https://conductscience.org/api/papers/v1/41301487/references?page=2